|
|
Product trade name: OncoScint CR 103
| Pharmaceutical active ingredients: |
| Indium In-111 Satumomab Pendetide |
| Available forms, composition and doses of OncoScint CR 103: |
| N / A |
| OncoScint CR 103 medical category: |
| Human:Diagnostic radiopharmaceuticals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V09IB02 - Indium (111In) satumomab pendetide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisBayer Schering PharmaCIS Espana |
Pharmaceutical drugs, medications and other health products with similar to OncoScint CR 103 trade names:
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Oncoredox | Triaziquone | Unidentified Pharmaceutical Company | | Oncoril | Gemcitabine Hydrochloride | Naprod Life Sciences; Ambica International Trading Corporation | | Oncosal | Flutamide | Inibsa Laboratorios | | OncoScint | Indium In-111 Satumomab Pendetide | Cytogen; REM, Brazil | | OncoScint CR / OV | Indium In-111 Satumomab Pendetide | Cytogen | | OncoSeeds | Titanium Iodine, I-125 | Amersham | | Oncosid | Etoposide | United Biotech | | Oncostatin K | Actinomycin | Unidentified Pharmaceutical Company | | Oncostin | Vinblastine Sulfate | Cipla; Phil Pharmawealth | | Oncotam | Tamoxifen Citrate | Mayoly Spindler Laboratoires; Zydus Cadila |
Compare some medical and health care products with the same or related to OncoScint CR 103 active ingredients:
More pharmaceutical products manufactured or supplied by the same as OncoScint CR 103 and similar pharmaceutical companies:
|
|